POSTERIOR SUBCAPSULAR CATARACT FOLLOWING PROLONGED ORAL STEROID USE FOR ALLERGIC CONJUNCTIVITIS: A CASE REPORT

  • AJAYI IYIADE ADESEYE Department of Ophthalmology, Ekiti State University Teaching Hospital, Ado-Ekiti, Nigeria.
  • OMOTOYE OLUSOLA JOSEPH Department of Ophthalmology, Ekiti State University Teaching Hospital, Ado-Ekiti, Nigeria.
  • OLULEYE TITILOPE TAIYE Department of Ophthalmology, Ekiti State University Teaching Hospital, Ado-Ekiti, Nigeria.

Abstract

Objective: We present a case of a 27-year-old female trader with a month history of bilateral painless progressive blurring of vision which was worse for distant vision after a 4-year daily use of oral prednisolone (10 mg) prescribed by a non-ophthalmologist. The conventional treatment for ocular allergy includes avoidance of allergens, topical antihistamines, mast cell stabilizers, topical corticosteroids, oral antihistamines, nonsteroidal anti-inflammatory drugs, and corticosteroids. However, inappropriate steroid use can be associated with undesirable complications.


Methods: A case report of a 27 year old female trader who presented with blurring of vision associated with glare at night. There was history of daily intake of oral prednisolone for 4 years for treatment of allergic conjunctivitis.


Results: Examination revealed posterior subcapsular cataract due to prolonged steroid use. Steroid was gradually tapered and withdrawn over a week and the patient was refracted with good visual improvement.


Conclusion: Steroids should be reserved for severe cases and when utilized should be used as pulsed or short course therapy after baseline examination by Ophthalmologists.

Keywords: Cataract, Steroid, Treatment, Visual, Impairment

References

1. Deka M, Ahmed AB, Chakraborty J. Development, evaluation and characteristics of ophthalmic in situ gel system: A review. Int J Curr Pharm Res 2019;11:47-53.
2. Ono SJ, Abelson MB. Allergic conjunctivitis: Update on pathophysiology and prospects for future treatment. J Allergy Clin Immunol 2005;115:118-22.
3. Friedlaender MH. Ocular allergy. Curr Opin Allergy Clin Immunol 2011;11:477-82.
4. Bhosale NR, Kolte NS. Formulation development and evaluation of orally disintegrating tablet of orally disintegrating tablet of chlorpheniramine maleate by sublimation technique. Int J Pharm Pharm Sci 2019;11:28-36.
5. Fasasi MK, Kabir AA, Hamza BA, Richard AI, Sadiat SE, Abdulfattah I. Allergic conjunctivitis in a tertiary eye hospital, Nigeria. J Kathmandu Med Coll 2014;3:149-52.
6. Satyam SM, Adiga S, Chogtu B, Bairy KL, Pirasanthan R, Vaishnav RL. Effect of fucithalmic and sofinox eye drops on experimental allergic conjunctivitis in rats. Int J Pharm Pharm Sci 2014;6:458-60.
7. La Rosa M, Lionetti E, Reibaldi M, Russo A, Longo A, Leonardi S, et al., Allergic conjunctivitis: A comprehensive review of the literature. Ital J Pediatr 2013;39:18.
8. Comstock TL, Decoy HH. Advances in corticosteroids therapy for ocular inflammation: Loteprednol etabonate. Int J Inflam 2012;2012:789623.
9. James ER. The etiology of steroid cataract. J Ocul Pharmacol Ther 2007;23:403-20.
10. Jobling AI, Augusteyn RC. What causes steroid cataracts? A review of steroid-induced posterior subcapsular cataracts. Clin Exp Optom 2002;85:61-75.
Statistics
92 Views | 54 Downloads
How to Cite
AJAYI IYIADE ADESEYE, OMOTOYE OLUSOLA JOSEPH, & OLULEYE TITILOPE TAIYE. (2019). POSTERIOR SUBCAPSULAR CATARACT FOLLOWING PROLONGED ORAL STEROID USE FOR ALLERGIC CONJUNCTIVITIS: A CASE REPORT. Innovare Journal of Health Sciences, 7(6). Retrieved from https://innovareacademics.in/journals/index.php/ijhs/article/view/35797
Section
Case Study(s)